No Data
October 17th [Today's Investment Strategy]
[Fisco Selected Stock] [Material Stock] SIG Group <4386> 622 yen (10/16) Engaged in system development including DX support, operation of server/network equipment and software, maintenance, etc. Upwardly revised the financial estimates for the fiscal year ending March 2025. Operating profit is expected to be 30.6 million yen (67.2% increase from the previous year). This is raised by about 62% from the previous forecast. Orders are strong, and the subsidiary acquired at the end of the previous period is also performing well. Profit margin improvement has progressed, partially due to some expenses budget remaining unexecuted.
Pay attention to biochemistry and SIG Group.
On the 16th in the US stock market yesterday, the dow jones industrial average closed at 43,077.70, up 337.28 points, while the nasdaq composite index rose 51.49 points to 18,367.08. In Chicago, the Nikkei 225 futures on the Osaka Exchange saw a 260 yen increase over the daytime session to 39,450 yen. The exchange rate was 1 dollar = 149.50-60 yen. In today's Tokyo market, Hamakyore <9037> announced a share buyback with a maximum of 0.27% of the issued shares and a buying commission, with a total revenue of September increasing by 11.9% from the previous month's 7.3%, expanding the growth rate.
Daiseki Eco Solution: Interim report - 29th period (2024/03/01 - 2025/02/28)
Daiseki Eco. Solution's Attributable Profit Falls 45% in H1
Volume change rate ranking (9 o'clock) ~ ABEJA, Kasumigaseki CA, etc. ranked
In the volume change rate ranking, you can understand the market participants' interest such as trends in speculative activities by comparing the average volume of the last 5 days with the volume on the day of distribution. Top Volume Change Rate [As of 9:32 on October 3] (Compared to the average volume of the last 5 days) Stock Code Stock Name Volume 5-Day Average Volume Volume Change Rate Stock Price Change Rate <133A> GX Super Short Grain 31011 107,185.08 204.85% 0.0215
October 1st [Today's investment strategy]
[Fisco Selected Stocks] [Material Stocks] Nexera Pharma <4565> 1226 yen (10/1) Drug discovery venture. Former Sosei Group. Its subsidiary Nexera Pharma Japan has announced the signing of a partnership agreement with Shionogi <4507> regarding the distribution and sales of the insomnia treatment drug "Cubick Tablets" in Japan, and resolved its sales efforts with Mochida Pharmaceutical <4534>. Shionogi will independently conduct distribution and sales activities in Japan. [Emerging Markets]
No Data
No Data